Nicotine transdermal systems

OBJECTIVE: To review the role of transdermal nicotine as an aid to smoking cessation. DATA SOURCES: A MEDLINE search was performed that included clinical studies published in English involving transdermal nicotine; references used in those articles were screened for additional published information. STUDY SELECTION: Published clinical trials were reviewed with particular emphasis on controlled trials that evaluated safety and efficacy. DATA SYNTHESIS: Transdermal nicotine therapy has been shown to be a safe and effective pharmacologic aid in a smoking cessation program when used in conjunction with a psychologic or behavior support system. Habitrol, Nicoderm, Nicotrol, and PROSTEP differ in some characteristics (i.e., delivery systems, total nicotine content and amount absorbed, rate of delivery, recommended duration of application); however, the clinical implication of these differences has not been determined. CONCLUSIONS: Transdermal nicotine is effective for patients who are motivated to quit smoking and receive concomitant behavior support.

This article has been cited by other articles:

				S. A. Duffy, D. L. Ronis, M. Valenstein, K. E. Fowler, M. T. Lambert, C. Bishop, J. E. Terrell, and the University of Michigan Head and Neck Cancer Te Depressive Symptoms, Smoking, Drinking, and Quality of Life Among Head and Neck Cancer Patients Psychosomatics, April 1, 2007; 48(2): 142 - 148. [Abstract] [Full Text] [PDF]

				M. Davidson, M. Epstein, R. Burt, C. Schaefer, G. Whitworth, and A. McDonald Efficacy and Safety of an Over-the-counter Transdermal Nicotine Patch as an Aid for Smoking Cessation Arch Fam Med, November 1, 1998; 7(6): 569 - 574. [Abstract] [Full Text] [PDF]

				Committee on Drugs Alternative Routes of Drug Administration---Advantages and Disadvantages (Subject Review) Pediatrics, July 1, 1997; 100(1): 143 - 152. [Abstract] [Full Text] [PDF]